CAS: 2130996-00-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GLPG2938 REF: AN-AG01X7A2CAS: 2130996-00-6 | 97% | 175,00 €~471,00 € | Jue 02 May 24 |
 | GLPG2938 REF: TM-T9199CAS: 2130996-00-6 | 98.1% | 82,00 €~1.068,00 € | Jue 09 May 24 |
 | GLPG2938 REF: 3D-FKD99600CAS: 2130996-00-6 | Min. 95% | A consultar | Jue 13 Jun 24 |
Ref: AN-AG01X7A2
| 25mg | 175,00 € | |
| 50mg | 295,00 € | |
| 100mg | 471,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
GLPG2938
CAS:2130996-00-6
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) is a potent and selective antagonist of S1P2.
Fórmula:
C20H19F6N7O2
Pureza:
98.1%
Forma y color:
Solid
Peso molecular:
503.4
Ref: TM-T9199
| 1mg | 82,00 € | |
| 5mg | 158,00 € | |
| 10mg | 270,00 € | |
| 25mg | 537,00 € | |
| 50mg | 774,00 € | |
| 100mg | 1.068,00 € | |
| 1ml*10 (DMSO) | 167,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
GLPG2938
CAS:2130996-00-6
GLPG2938 is a small molecule inhibitor of the extracellular, membrane-bound form of the human insulin …
Fórmula:
C20H19F6N7O2
Pureza:
Min. 95%
Peso molecular:
503.40 g/mol
Ref: 3D-FKD99600
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
